İçeriğe geç
akaturk Akademik ölçüm
Akademik özet YÖKSİS ve OpenAlex ayrı sayılır.
Makale 39
YÖKSİS39 OpenAlex0
Proje 7
Kitap 10
Bildiri 93

Atıf etkisi

OpenAlex YÖKSİS makalelerinden OpenAlex’te eşleşen: 8
h-indeks 4 Türkiye yüzdelik dilimi: 58 Üniversitesinde h-indekse göre 246. / 570
i10-indeks
1
Toplam atıf
61
Türkiye’de üst %41
Makale başına
7,6
FWCI
1,84
1,00 = dünya ortalaması
Dünyada üst %1
0
Dünyada üst %10
3

h-indeks ve atıflar, bu akademisyenin YÖKSİS makalelerinden OpenAlex’te eşleşenlerin atıf sayılarından hesaplanır (Google Scholar, WoS veya Scopus değildir). Eşleşmeyen makalelerin atıfı dahil değildir.

Alan sıralaması

YÖKSİS ?

Dizin çeyrekleri

?
Scopus (SJR) 34
  • Q1 13
  • Q2 7
  • Q3 7
  • Q4 7
WoS (JCR) 33
  • Q1 6
  • Q2 9
  • Q3 10
  • Q4 8
TR Index TR Index

14 makale

OpenAlex atıf yüzdelik
  • Üst %1 0
  • Üst %10 3
  • Ort. 73.6%
  • n 8
Diğer sayımlar

Scopus (SJR)

  • YÖKSİS satırı 34

WoS (JCR)

  • YÖKSİS satırı 33

Makaleler

YÖKSİS ve OpenAlex kaynak ayrımıyla makaleler; quartile ve TR Index ile daraltabilirsiniz.

Yayını olan dergiler

26 dergi

Makale listesi

  1. 2026 Defining inactivity of juvenile spondyloarthropathies: Delphi study among Pediatric Rheumatology Academy (PeRA) from Türkiye International Journal of Rheumatic Diseases DOI 10.1111/1756-185x.70606 YÖKSİS SJR Q3 JCR Q3
  2. 2026 Factors predicting the severity of gastrointestinal involvement in children with IgA vasculitis? A Turkish multicenter cohort study European Journal of Pediatrics DOI 10.1007/s00431-026-07162-4 YÖKSİS SJR Q1 JCR Q1
  3. 2026 Childhood-onset versus adult-onset Sjögren Syndrome: Clinical phenotype, disease activity, and predictors of organ damage in a national multicenter cohort Seminars in Arthritis and Rheumatism DOI 10.1016/j.semarthrit.2026.153060 YÖKSİS SJR Q1 JCR Q2
  4. 2026 Oral health status and subgingival microbiota in children with juvenile idiopathic arthritis Frontiers in Cellular and Infection Microbiology DOI 10.3389/fcimb.2026.1831655 YÖKSİS SJR Q1 JCR Q1
  5. 2026 Tumor necrosis factor inhibitor-related autoimmune disorders in pediatric rheumatology practice: a multicenter nationwide study Pediatric Rheumatology DOI 10.1186/s12969-026-01236-1 YÖKSİS SJR Q1 JCR Q2
  6. 2025 Cyclophosphamide treatment with a comparison in both pediatric rheumatology and pediatric nephrology practices Pediatric Rheumatology DOI 10.1186/s12969-025-01080-9 YÖKSİS SJR Q1 JCR Q2 OpenAlex üst %10 OpenAlex 92.5%
  7. 2025 Predicting homozygous M694V genotype in paediatric FMF: multicentre analysis and scoring system proposal Rheumatology (Oxford) DOI 10.1093/rheumatology/keaf221 YÖKSİS SJR Q1 JCR Q1
  8. 2025 How early is early for JIA? Insights from the infantile-onset juvenile idiopathic arthritis patients of the PERA research group cohort Rheumatology DOI 10.1093/rheumatology/keaf440 YÖKSİS SJR Q1 JCR Q1 OpenAlex 89.2%
  9. 2025 A rare manifestation of Henoch–Schoenlein purpura: haemoptysis secondary to pulmonary involvement – a case report Paediatrics and International Child Health DOI 10.1080/20469047.2025.2550046 YÖKSİS SJR Q2 JCR Q3 OpenAlex 25.7%
  10. 2025 Longitudinal assessment of disease burden in juvenile systemic lupus erythematosus: A multicenter study of activity and damage scores Lupus DOI 10.1177/09612033251386091 YÖKSİS SJR Q2 JCR Q3 OpenAlex 76.3%
  11. 2025 Results of a Nationwide Multicenter Study in Childhood Sjögren Disease The Journal of Rheumatology DOI 10.3899/jrheum.2024-1048 YÖKSİS SJR Q2 JCR Q2 OpenAlex üst %10 OpenAlex 95.2%
  12. 2025 Comment on: How early is early for JIA? Insights from the infantile-onset juvenile idiopathic arthritis patients of the PERA research group cohort: Reply Rheumatology DOI 10.1093/rheumatology/keaf683 YÖKSİS SJR Q1 JCR Q1
  13. 2025 Panniculitis in Anti-MDA-5 Positive Juvenile Dermatomyositis: A Case Report Journal of Nepal Medical Association DOI 10.31729/jnma.8874 YÖKSİS SJR Q3 JCR Q4
  14. 2024 Evaluation of pediatric rheumatologists' approach to rituximab use: a questionnaire study European journal of pediarics DOI 10.1007/s00431-024-05654-9. YÖKSİS SJR Q1 JCR Q1
  15. 2024 Consensus on transition care for juvenile idiopathic arthritis: a Delphi study with youth, caregivers, and health professionals Pediatric rheumatology online journal DOI 10.1186/s12969-024-01047-2. YÖKSİS SJR Q1 JCR Q2
  16. 2024 Towards a standardized program of transitional care for adolescents with juvenile idiopathic arthritis for Turkey: a national survey study Pediatric rheumatology online journal DOI 10.1186/s12969-023-00943-3. YÖKSİS SJR Q1 JCR Q2
  17. 2024 Latent Tuberculosis Infection in Children with Pediatric Rheumatologic Diseases Treated with Canakinumab Journal of Pediatric Infection DOI 10.5578/ced.20240304 YÖKSİS TR Index SJR Q4 JCR Q4
  18. 2024 Is there any difference between M694V heterozygote and non-exon 10 mutations on symptoms onset and response to colchicine treatment? Pamukkale Tıp Dergisi DOI 10.31362/patd.1496674 YÖKSİS TR Index SJR Q4
  19. 2024 Mediterranean Fever (MEFV) Gene Variants in Kawasaki Disease in Turkish Children: Do They Influence the Disease Course? Journal of Clinical Practice and Research DOI 10.14744/cpr.2024.83003 YÖKSİS TR Index JCR Q4
  20. 2023 Exploring the immunological basis of periodic fever, aphthous stomatitis, pharyngitis, and adenitis (PFAPA) syndrome: immunohistochemical staining features of palatine tonsils Clinical Rheumatology DOI 10.1007/s10067-023-06563-2 YÖKSİS SJR Q2 JCR Q2

Akademisyenlere dön